Partnership Call to Action
The Revolutionary Breakthrough: From Insect Control to Disease Elimination
For 150 years, we've fought vector-borne diseases by targeting the insect vectors—killing them with insecticides, destroying habitats, suppressing populations, modifying genetics, or infecting them with bacteria. None of which have sustained disease protection, all of which have negative environmental impact. ArboShield™ changes everything: it's the first biocontrol technology that doesn't affect insects or the environment; it targets the disease itself.
The World Mosquito Program’s (WMP) Wolbachia-based dengue control approach established a regulatory pathway, community engagement and demonstrated the effectiveness of biocontrol; however, it has certain limitations. Notably, its efficacy is restricted to Ae. aegypti mosquitoes, primarily by reducing their population. In contrast, ArboShield™ is designed to eliminate pathogenic virus genomes across a broad range of insect populations while preserving the integrity of the ecosystem.
The Choice: Repeating what doesn't work, or Revolutionary Change
Traditional methods—pesticides, population suppression, human vaccination—continue the cycle of outbreak, response, and resurgence. ArboShield™ Revolutionary approach eliminates the problem at its source; removing pathogenic viruses from the environment while building comprehensive human and animal immunity and preserving ecological balance.
Collaboration is the Key to Success
The Partnership Opportunity
Vacunax is seeking strategic collaboration partners for field validation of the first vector-neutral biocontrol technology.
For Government Partners: Lead Your Region's Health Innovation
Eliminate vector-borne diseases from your territory using breakthrough technology
Establish international leadership in innovative biocontrol implementation for strategic health security
Protect your population while preserving environmental and ecological balance
Reduce the Healthcare burden as vector-borne diseases cost the LMIC economy's $100B+ annually
Preferential treatment for broader deployment across your region
For NGO & International Organizations: Transform Your Disease Control Impact
Deploy game-changing technology that eliminates rather than controls disease
Achieve unprecedented efficacy in vector-borne disease intervention
Partner with breakthrough science that advances global health innovation
Generate global recognition as a pioneer in next-generation disease control
Establish sustainable programs that continue protecting communities long-term
For Impact Investors & Philanthropists: Fund the Future of Global Health
Invest in revolutionary technology with massive global scale potential
Generate exceptional impact ROI protecting millions while preserving ecosystems
Partner with world-class science and proven implementation expertise
Access commercial upside through preferred licensing and IP sharing
Lead transformation from reactive disease control to proactive elimination
Ready to Make History?
The first ArboShield™ field deployment will define the future of vector control globally. Your partnership makes it possible.
Priority given to high-burden key pathogen locations with strong regulatory pathways and community engagement capabilities.
Contact Information:
Dr. Richard Anthony, PhD
Founder & President
📧 ranthony@vacunax.com
📞 +1-626-437-7258
Immediate Response Guaranteed: All partnership inquiries receive response within 48 hours.
This isn't just better biocontrol. This is biological vaccination at ecosystem scale.
Contact
Reach out for partnerships or inquiries
Phone
info@vacunax.com
+1-626-437-7258
© 2026. Vacunax Inc. All rights reserved.
